Position in HLN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,604
-$117 QoQ
Shares Held
172
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#579
of 639 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Aventura Private Wealth, LLC holds $80,730 across 8 Drug Manufacturers - Specialty & Generic names. HLN ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
441 | $31,690 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
111 | $18,707 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
19 | $10,294 | |
| 4 | PRGO |
PERRIGO Co plc
|
679 | $7,054 | |
| 5 | VTRS |
Viatris Inc
|
351 | $5,573 | |
| 6 | CRON |
Cronos Group Inc.
|
1,920 | $5,337 | |
| 7 | HLN |
Haleon plc
This page
|
172 | $1,604 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
105 | $471 |
All Filings in HLN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,604 | 172 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,721 | 172 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,738 | 172 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,542 | 172 | Shares | Sole | 2026-01-07 | |
| 2025-06-30 | $1,783 | 172 | Shares | Sole | 2026-01-07 | |
| No filing history on record for this holder in this stock. | ||||||